Sector
PharmaceuticalsOpen
₹19.04Prev. Close
₹18.61Turnover(Lac.)
₹90.06Day's High
₹19.25Day's Low
₹18.152 Week's High
₹34.752 Week's Low
₹12Book Value
₹-75.21Face Value
₹2Mkt Cap (₹ Cr.)
98.69P/E
12.59EPS
1.44Divi. Yield
02 Sep 2024
12:00 AM
AGM
Announcement Date: 02 Sep, 2024
19 Jun 2025
12:00 AM
Board Meeting
Agenda : Audited Result
20 Jan 2025
12:00 AM
EGM
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 10.83 | 10.83 | 10.83 | 10.83 |
Preference Capital | 14.2 | 14.2 | 14.2 | 14.2 |
Reserves | -701.66 | -715.53 | -731.15 | -706 |
Net Worth | -676.63 | -690.5 | -706.12 | -680.97 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 356.05 | 329.52 | 269.81 | 263.05 |
yoy growth (%) | 8.05 | 22.12 | 2.56 | -14.52 |
Raw materials | -186.52 | -186.89 | -154.15 | -166.02 |
As % of sales | 52.38 | 56.71 | 57.13 | 63.11 |
Employee costs | -55.79 | -52.52 | -48.26 | -42.38 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -28.28 | -23.06 | -25.22 | -103.76 |
Depreciation | -32.7 | -33.59 | -34.63 | -35.73 |
Tax paid | -0.32 | -2.46 | -0.75 | -0.89 |
Working capital | -9.72 | -14.89 | -20.1 | -383.71 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 8.05 | 22.12 | 2.56 | -14.52 |
Op profit growth | 77.3 | 270.66 | -109.62 | -58.33 |
EBIT growth | 219.15 | -130.93 | -79.22 | -51.62 |
Net profit growth | 55.93 | -64.67 | -85.14 | 82.18 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2018 |
|---|---|---|---|---|---|
Gross Sales | 515.23 | 502.25 | 410.96 | 397.71 | 270.57 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 515.23 | 502.25 | 410.96 | 397.71 | 270.57 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 327.58 | 57.65 | 72.43 | 24.28 | 10.16 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & CEO
G Munjal
Executive Chairman
S R Mehta
Joint Managing Director
V R Mehta
Non-Exec & Non-Independent Dir
Himanshu Jain
Non-Exec & Non-Independent Dir
N R Munjal
Non-Exec & Non-Independent Dir
Rishav Mehta
Non-Exec. & Independent Dir.
Subhash Chander Galhotra
Non-Exec. & Independent Dir.
Anoop Michra
Non-Exec. & Independent Dir.
Jagvir Singh Ahluwalia
Non-Exec. & Independent Dir.
Bhupinder Singh
Non-Exec. & Independent Dir.
Subodh Gupta
Non-Exec. & Independent Dir.
Prabhat Khurana
Company Sec. & Compli. Officer
Puneet Khurana
781 Industrial Area Phase-II,
Ram Darbar,
Chandigarh - 160002
Tel: 91-0172-2638781-786
Website: http://www.indswiftltd.com
Email: [email protected]
Alankit House,
4E/2 Jhandewalan Ext,
New Delhi - 110055
Tel: 91-11-42541201
Website: www.alankit.com
Email: info2alankit.com
Summary
Ind-Swift Limited (ISL) is an India-based pharmaceutical company. The Company is engaged in the manufacturing and marketing of pharmaceutical finished dosage. The products manufactured by the company ...
Read More
Reports by Ind-Swift Ltd
What is the Ind-Swift Ltd share price today?
What is the Market Cap of Ind-Swift Ltd?
What is the PE and PB ratio of Ind-Swift Ltd?
What is the 52 Week High and Low of Ind-Swift Ltd?
What is the CAGR of Ind-Swift Ltd?
What is the shareholding pattern of Ind-Swift Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.